SARS-CoV-2 BA.4 infection triggers more cross-reactive neutralizing antibodies than BA.1
S. Richardson, T. Motlou, M. van der Mescht, B. Lambson, J. Everatt, D. Amoako, A. Van Gottberg, N. Wolter, Z. de Beer, T. Roma de Villiers, A. Bodenstein, G. van den Berg, T. M. Rossouw, M. Boswell, V. Ueckermann, , P. Moore
This study compares the neutralizing antibody responses to SARS-CoV-2 BA.4 and BA.1, finding BA.4 induces more cross-reactive antibodies, suggesting potential benefits for next-generation vaccines.
bioRxiv · Jul 14, 2022 · PreprintImmunology